Tue, October 11, 2022

Drew Ranieri Maintained (BVS) at Buy with Decreased Target to $11 on, Oct 11th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-11-on-oct-11th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Drew Ranieri of Morgan Stanley, Maintained "Bioventus Inc." (BVS) at Buy with Decreased Target from $12 to $11 on, Oct 11th, 2022.

Drew has made no other calls on BVS in the last 4 months.



There is 1 other peer that has a rating on BVS. Out of the 1 peers that are also analyzing BVS, all agrees with Drew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Amit Hazan of "Goldman Sachs" Maintained at Hold with Decreased Target to $13 on, Wednesday, September 7th, 2022